Active Immunization Targeting Amyloid β for the Treatment of Alzheimer's Disease.

In 2019, it was reported that Aβ antibodies were found in 96% of participants and that cognitive outcomes were improved after immunization, although this result did not reach statistical significance [ 82 ].

also in 111,027 other papers